Antiviral effects of quinine sulfate on HSV-1 HaCat cells infected: Analysis of the molecular mechanisms involved

被引:26
作者
Baroni, A.
Paotetti, I.
Ruocco, E.
Ayala, F.
Wolf, R.
Tufano, M. A.
机构
[1] Univ Naples 2, Fac Med & Surg, Dept Expt Med, Microbiol & Clin Microbiol Sect, I-80138 Naples, Italy
[2] Univ Naples 2, Fac Med & Surg, Dept Dermatol, I-80138 Naples, Italy
[3] Kaplan Med Ctr, Dermatol Unit, Rehovot, Israel
关键词
HSV-1; quinine sulfate; Hsp70; HaCat;
D O I
10.1016/j.jdermsci.2007.05.009
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:253 / 255
页数:3
相关论文
共 10 条
[1]   SELECTIVE-INHIBITION OF VIRUS PROTEIN-SYNTHESIS BY PROSTAGLANDIN A(1) - A TRANSLATIONAL BLOCK ASSOCIATED WITH HSP70 SYNTHESIS [J].
AMICI, C ;
GIORGI, C ;
ROSSI, A ;
SANTORO, MG .
JOURNAL OF VIROLOGY, 1994, 68 (11) :6890-6899
[2]   Herpes simplex virus disrupts NF-κB regulation by blocking its recruitment on the IκBα promoter and directing the factor on viral genes [J].
Amici, C ;
Rossi, A ;
Costanzo, A ;
Ciafrè, S ;
Marinari, B ;
Balsamo, M ;
Levrero, M ;
Santoro, MG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (11) :7110-7117
[3]   A RAPID MICROPREPARATION TECHNIQUE FOR EXTRACTION OF DNA-BINDING PROTEINS FROM LIMITING NUMBERS OF MAMMALIAN-CELLS [J].
ANDREWS, NC ;
FALLER, DV .
NUCLEIC ACIDS RESEARCH, 1991, 19 (09) :2499-2499
[4]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[5]   Immunomodulatory effects of a set of amygdalin analogues on human keratinocyte cells [J].
Baroni, A ;
Paoletti, I ;
Greco, R ;
Satriano, RA ;
Ruocco, E ;
Tufano, MA ;
Perez, JJ .
EXPERIMENTAL DERMATOLOGY, 2005, 14 (11) :854-859
[6]   Efficient replication by herpes simplex virus type 1 involves activation of the IκB kinase-IκB-p65 pathway [J].
Gregory, D ;
Hargett, D ;
Holmes, D ;
Money, E ;
Bachenheimer, SL .
JOURNAL OF VIROLOGY, 2004, 78 (24) :13582-13590
[7]   Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks [J].
Paton, NI ;
Aboulhab, J .
HIV MEDICINE, 2005, 6 (01) :13-20
[8]  
SHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111
[9]   Antimalarials: Unapproved uses or indications [J].
Wolf, R ;
Wolf, D ;
Ruocco, V .
CLINICS IN DERMATOLOGY, 2000, 18 (01) :17-35
[10]  
Wolf Ronni, 2003, Dermatol Online J, V9, P3